SUPN market cap is ~$265M (OS ~31M shares) with 2 approved drugs now selling (the 1st since feb.13 and the 2nd since sept.13) and getting royalties from a 3rd now. they've enough cash through 2014, some p2 drugs in the pipeline and are expecting to be cashflow breakeven at the end of 2014. and there are about 28% shares of float short 11/29/2013 with insider holding 25.4M shares per 09/30/2013.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.